These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31321754)

  • 21. Laboratory-confirmed reinfections with Bordetella pertussis.
    Versteegh FG; Schellekens JF; Nagelkerke AF; Roord JJ
    Acta Paediatr; 2002; 91(1):95-7. PubMed ID: 11885549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pertussis resurgence among vaccinated children in Khairpur, Sindh, Pakistan.
    Mughal A; Kazi YF; Bukhari HA; Ali M
    Public Health; 2012 Jun; 126(6):518-22. PubMed ID: 22445714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.
    Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A
    Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do Pertussis Vaccines Protect Against Bordetella parapertussis?
    Liko J; Robison SG; Cieslak PR
    Clin Infect Dis; 2017 Jun; 64(12):1795-1797. PubMed ID: 28369240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are vaccination programs and isolate polymorphism linked to pertussis re-emergence?
    Godfroid F; Denoël P; Poolman J
    Expert Rev Vaccines; 2005 Oct; 4(5):757-78. PubMed ID: 16221076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB
    Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pertussis in the Association of Southeast Asian Nations: epidemiology and challenges.
    Thisyakorn U; Tantawichien T; Thisyakorn C; Buchy P
    Int J Infect Dis; 2019 Oct; 87():75-83. PubMed ID: 31369823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pertussis vaccines: acellular versus whole cell. Perhaps a return to the past?].
    Cofré J
    Rev Chilena Infectol; 2015 Oct; 32(5):559-63. PubMed ID: 26633113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.
    Weber C; Boursaux-Eude C; Coralie G; Caro V; Guiso N
    J Clin Microbiol; 2001 Dec; 39(12):4396-403. PubMed ID: 11724851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
    Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pertussis control: time for something new?
    Clark TA; Messonnier NE; Hadler SC
    Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal Immunity to
    Argondizo-Correia C; Rodrigues AKS; de Brito CA
    J Immunol Res; 2019; 2019():7134168. PubMed ID: 30882004
    [No Abstract]   [Full Text] [Related]  

  • 34. Evolution of Bordetella pertussis.
    He Q
    Pediatr Infect Dis J; 2016 Aug; 35(8):915-7. PubMed ID: 27213264
    [No Abstract]   [Full Text] [Related]  

  • 35. New pertussis vaccination approaches: en route to protect newborns?
    Locht C; Mielcarek N
    FEMS Immunol Med Microbiol; 2012 Nov; 66(2):121-33. PubMed ID: 22574832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlling pertussis: how can we do it? A focus on immunization.
    Martinón-Torres F; Heininger U; Thomson A; Wirsing von König CH
    Expert Rev Vaccines; 2018 Apr; 17(4):289-297. PubMed ID: 29482390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of adults in household outbreaks of pertussis.
    Baptista PN; Magalhães VS; Rodrigues LC
    Int J Infect Dis; 2010 Feb; 14(2):e111-4. PubMed ID: 19559636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas.
    Njamkepo E; Cantinelli T; Guigon G; Guiso N
    Microbes Infect; 2008; 10(14-15):1582-6. PubMed ID: 18977453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epidemic of erythromycin-resistant
    Yao K; Deng J; Ma X; Dai W; Chen Q; Zhou K; Ye J; Shi W; Wang H; Li D; Wang H; Wang J; Zhang J; Wu D; Xie G; Shen K; Zheng Y; Yang Y
    Expert Rev Vaccines; 2020 Nov; 19(11):1093-1099. PubMed ID: 33034224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pertussis vaccine for adolescents and adults].
    Perret P C
    Rev Chilena Infectol; 2006 Sep; 23(3):257-60. PubMed ID: 16896501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.